Global Antidiabetic Sulphonylureas Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.Biz delivers in-depth insights in its upcoming market report titled, “Global Antidiabetic Sulphonylureas Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global antidiabetic sulphonylureas market is estimated to register a CAGR of XX.X% in terms of revenue during the forecast period. Th report offers in-depth insights, revenue details, and other vital information regarding the global antidiabetic sulphonylurea market, the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, and their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. In this report, the global antidiabetic sulphonylurea market has been segmented on the basis of type, application, and region.

Request Covid - 19 Impact

Sulphonylureas are a class of organic compounds used in antidiabetic drugs that are widely used for management of type 2 diabetes mellitus. Antidiabetic sulphonylurea stimulate secretion of insulin from Beta cells in the pancreas, thus allowing the cells to use insulin better in response to rising levels of glucose in the blood. Major diabetes consequences include blindness, amputations, and kidney failure, with higher risk of death. According to the International Diabetes Federation, over XXX million people have been diagnosed with diabetes, and an additional XXX million are living undiagnosed currently.

Aging individuals and those with obesity are the key high-risk audience for diabetes. Increasing geriatric population, rising prevalence of obesity, and rising patient awareness levels are some major factors driving market growth. A number of initiatives aimed at providing cost-effective anti-diabetic drugs to patients by establishing a sophisticated healthcare reimbursement network is a key global trend in developed countries.

Introduction of new and more efficient diabetes treatment and monitoring products is also expected to boost market growth to a significant extent in future. However, side effects of medicines such as hypoglycemia or low blood glucose level, skin reactions, unusual hunger, weight gain, upset stomach (nausea, diarrhea, tendency to pass gas), and dark urine expression are some factors restraining growth of the global antidiabetic sulphonylures market. Also, pregnant women, individuals allergic to sulfa drugs, and those with kidney or liver diseases are not recommended to consume antidiabetic sulphonylures drugs, which is impacting growth of the target market significantly.

Global anti-diabetic sulphonylureas market segmentation by type:

• First Generation
• The Second Generation
• The Third Generation

Market segmentation by application:

• Hospitals
• Clinics
• Other

Market segmentation by region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa

• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Merck & Co.
• Eli Lilly
• Sanofi
• Takeda Pharmaceuticals
• Novo Nordisk
• Servier Laboratories
• Boehringer Ingelheim
• Bristol-Myers Squibb